Opioid-volatile anesthetic synergy: A response surface model with remifentanil and sevoflurane as prototypes

Anesthesiology

Volumn 105, Issue 2, 2006, Pages 267-278

  Manyam, Sandeep C ^a,b   Gupta, Dhanesh K ^b   Johnson, Ken B ^b   White, Julia L ^b   Pace, Nathan L ^b   Westenskow, Dwayne R ^b   Egan, Talmage D ^b  

^a Department of Electrical and Computer Engineering   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; REMIFENTANIL; SEVOFLURANE;

ADULT; ANALGESIA; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG POTENTIATION; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INFUSION PUMP; MALE; NOCICEPTIVE STIMULATION; NORMAL HUMAN; PHARMACODYNAMICS; PRESSURE SENSATION; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; SEDATION; THERMAL STIMULATION;

ADULT; ALGORITHMS; ANALGESICS, OPIOID; ANESTHETICS, INHALATION; COMPUTER SIMULATION; CONSCIOUS SEDATION; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; DRUG SYNERGISM; ENDPOINT DETERMINATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYL ETHERS; MODELS, STATISTICAL; PAIN MEASUREMENT; PIPERIDINES;

EID: 33746633896     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200608000-00009     Document Type: Article

References (59)

1. Zbinden AM, Petersen-Felix S, Thomson DA: Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia: II. Hemodynamic responses. ANESTHESIOLOGY 1994; 80:261-7
2. Eger EI II, Shafer SL: Tutorial: Context-sensitive decrement times for inhaled anesthetics. Anesth Analg 2005; 101:688-96
3. Katoh T, Kobayashi S, Suzuki A, Iwamoto T, Bito H, Ikeda K: The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. ANESTHESIOLOGY 1999; 90:398-405
4. Kazama T, Ikeda K, Morita K: Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. ANESTHESIOLOGY 1997; 87:213-27
5. Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Smith LR, Canada AT, Glass PS: The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. ANESTHESIOLOGY 1994; 81:820-8
6. Vuyk J, Lim T, Engbers FH, Burm AG, Vletter AA, Bovill JG: Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients. ANESTHESIOLOGY 1993; 78:1036-45
7. Hall RI, Szlam F, Hug CC Jr: The enflurane-sparing effect of alfentanil in dogs. Anesth Analg 1987; 66:1287-91
8. Vuyk J, Mertens MJ, Olofsen E, Burm AG, Bovill JG: Propofol anesthesia and rational opioid selection: Determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. ANESTHESIOLOGY 1997; 87:1549-62
9. Vuyk J, Lim T, Engbers FH, Burm AG, Vletter AA, Bovill JG: The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. ANESTHESIOLOGY 1995; 83:8-22
10. Glass PS, Gan TJ, Howell S, Ginsberg B: Drug interactions: Volatile anesthetics and opioids. J Clin Anesth 1997;9:18S-22S
11. Bouillon TW, Bruhn J, Radulescu L, Andresen C, Shafer TJ, Cohane C, Shafer SL: Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, Bispectral Index, and electroencephalographic approximate entropy. ANESTHESIOLOGY 2004; 100:1353-72
12. Greco WR, Bravo G, Parsons JC: The search for synergy: A critical review from a response surface perspective. Pharmacol Rev 1995; 47:331-85
13. Kern SE, Xie G, White JL, Egan TD: A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers. ANESTHESIOLOGY 2004; 100:1373-81
14. Minto C, Vuyk J: Response surface modelling of drug interactions. Adv Exp Med Biol 2003; 523:35-43
15. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL: Response surface model for anesthetic drug interactions. ANESTHESIOLOGY 2000; 92:1603-16
16. Short TG, Ho TY, Minto CF, Schnider TW, Shafer SL: Efficient trial design for eliciting a pharmacokinetic-pharmacodynamic model-based response surface describing the interaction between two intravenous anesthetic drugs. ANESTHESIOLOGY 2002; 96:400-8
17. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, Billard V, Hoke JF, Moore KH, Hermann DJ, Muir KT, Mandema JW, Shafer SL: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: I. Model development. ANESTHESIOLOGY 1997; 86:10-23
18. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL: Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: Study with intravenous midazolam. J Clin Psychopharmacol 1990; 10:244-51
19. Cormack RS, Lehane J: Difficult tracheal intubation in obstetrics. Anaesthesia 1984; 39:1105-11
20. Prys-Roberts C: Anaesthesia: A practical or impractical construct? Br J Anaesth 1987; 59:1341-5
21. Zhang Y, Eger EI II, Dutton RC, Sonner JM: Inhaled anesthetics have hyperalgesic effects at 0.1 minimum alveolar anesthetic concentration. Anesth Analg 2000; 91:462-6
22. Egan TD, Minto C: Common pharmacodynamic drug interactions in anesthetic practice, Anesthetic Pharmacology: Physiologic Principles & Clinical Practice. Edited by Evers AX, Maze M. London, Churchill Livingstone, 2004, pp 94-7
23. Jacquez JA, Perry T: Parameter estimation: Local identifiability of parameters. Am J Physiol 1990; 258:E727-36
24. Glantz SA, Slinker KK: Primer of Applied Regression and Analysis of Variance, 2nd edition. New York, McGraw-Hill, 2001, pp 118-9
25. Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. ANESTHESIOLOGY 1991; 74:53-63
26. Lerou JG, Booij LH: Model-based administration of inhalation anaesthesia: I. Developing a system model. Br J Anaesth 2001; 86:12-28
27. Zbinden AM, Maggiorini M, Petersen-Felix S, Lauber R, Thomson DA, Minder CE: Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia: I. Motor reactions. ANESTHESIOLOGY 1994; 80:253-60
28. Knuth D: Sorting and Searching: The Art of Computer Programming, 3rd edition. Reading, Massachusetts, Addison-Wesley, 1997, pp 409-26
29. Short TG, Plummer JL, Chui PT: Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br J Anaesth 1992; 69:162-7
30. Mertens MJ, Olofsen E, Engbers FH, Burm AG, Bovill JG, Vuyk J: Propofol reduces perioperative remifentanil requirements in a synergistic manner: Response surface modeling of perioperative remifentanil-propofol interactions. ANESTHESIOLOGY 2003; 99:347-59
31. Nieuwenhuijs DJ, Olofsen E, Romberg RR, Sarton E, Ward D, Engbers F, Vuyk J, Mooren R, Teppema LJ, Dahan A: Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and Bispectral Index. ANESTHESIOLOGY 2003; 98:312-22
32. Dahan A, Nieuwenhuijs D, Olofsen E, Sarton E, Romberg R, Teppema L: Response surface modeling of alfentanil-sevoflurane interaction on cardiorespiratory control and Bispectral Index. ANESTHESIOLOGY 2001; 94:982-91
33. Lysakowski C, Dumont L, Pellegrini M, Clergue F, Tassonyi E: Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia. Br J Anaesth 2001; 86:523-7
34. Vuyk J, Hennis PJ, Burm AG, de Voogt JW, Spierdijk J: Comparison of midazolam and propofol in combination with alfentanil for total intravenous anesthesia. Anesth Analg 1990; 71:645-50
35. Mertens MJ, Olofsen E, Burm AG, Bovill JG, Vuyk J: Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics. ANESTHESIOLOGY 2004; 100:795-805
36. Bol CJ, Vogelaar JP, Tang JP, Mandema JW: Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat. J Pharmacol Exp Ther 2000; 294:347-55
37. Berenbaum MC: What is synergy? Pharmacol Rev 1989; 41:93-141
38. Katoh T, Ikeda K: The minimum alveolar concentration (MAC) of sevoflurane in humans. ANESTHESIOLOGY 1987; 66:301-3
39. Hall RI, Murphy MR, Hug CC Jr: The enflurane sparing effect of sufentanil in dogs. ANESTHESIOLOGY 1987; 67:518-25
40. Katoh T, Suguro Y, Ikeda T, Kazama T, Ikeda K: Influence of age on awakening concentrations of sevoflurane and isoflurane. Anesth Analg 1993; 76:348-52
41. Hug CC Jr: Does opioid "anesthesia" exist? ANESTHESIOLOGY 1990; 73:1-4
42. Philbin DM, Rosow CE, Schneider RC, Koski G, D'Ambra MN: Fentanyl and sufentanil anesthesia revisited: How much is enough? ANESTHESIOLOGY 1990; 73:5-11
43. Wong KC: Narcotics are not expected to produce unconsciousness and amnesia. Anesth Analg 1983; 62:625-6
44. Katoh T, Ikeda K: The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. ANESTHESIOLOGY 1998; 88:18-24
45. Syroid ND, Agutter J, Drews FA, Westenskow DR, Albert RW, Bermudez JC, Strayer DL, Prenzel H, Loeb RG, Weinger MB: Development and evaluation of a graphical anesthesia drug display. ANESTHESIOLOGY 2002; 96:565-75
46. Miller DR, Tierney M: Observational studies and "real world" anesthesia pharmacoeconomics/Les etudes par observation et la realite pharmacoeconomique de l'anesthesie. Can J Anesth 2002; 49:329-34
47. Avram MJ, Krejcie TC: Using front-end kinetics to optimize target-controlled drug infusions. ANESTHESIOLOGY 2003; 99:1078-86
48. Mertens MJ, Engbers FH, Burm AG, Vuyk J: Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia. Br J Anaesth 2003; 90:132-41
49. Egan TD, Huizinga B, Gupta SK, Jaarsma RL, Sperry RJ, Yee JB, Muir KT: Remifentanil pharmacokinetics in obese versus lean patients. ANESTHESIOLOGY 1998; 89:562-73
50. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. ANESTHESIOLOGY 1993; 79:881-92
51. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL: Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. ANESTHESIOLOGY 1996; 84:821-33
52. Eger EI II, Laster MJ, Gregory GA, Katoh T, Sonner JM: Women appear to have the same minimum alveolar concentration as men: A retrospective study. ANESTHESIOLOGY 2003; 99:1059-61
53. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M: Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003; 106:49-57
54. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M: Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. ANESTHESIOLOGY 2000; 93:409-17
55. Lotsch J, Angst MS: The mu-opioid agonist remifentanil attenuates hyperalgesia evoked by blunt and punctuated stimuli with different potency: A pharmacological evaluation of the freeze lesion in humans. Pain 2003; 102:151-61
56. Schumacher PM, Bouillon TW, Leibundgut D, Sartori V, Zbinden AM: Anesthesia Advisory Display (AAD): Real time guidance through the pharmacokinetic and interaction pharmacodynamic relationship during simultaneous administration of multiple drugs (abstract). ANESTHESIOLOGY 2004; 101:A504
57. Lowe HJ, Ernst EA: The Quantitative Practice of Anesthesia: Use of Closed Circuit. Baltimore, Williams & Wilkins, 1981, pp 118-9
58. Kennedy RR, French RA, Spencer C: Predictive accuracy of a model of volatile anesthetic uptake. Anesth Analg 2002; 95:1616-21
59. Van Poucke GE, Bravo LJ, Shafer SL: Target controlled infusions: Targeting the effect site while limiting peak plasma concentration. IEEE Trans Biomed Eng 2004; 51:1869-75